Masimo Co. (MASI) Stake Increased by New Amsterdam Partners LLC NY

Share on StockTwits

New Amsterdam Partners LLC NY grew its stake in shares of Masimo Co. (NASDAQ:MASI) by 22.8% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 99,769 shares of the medical equipment provider’s stock after acquiring an additional 18,492 shares during the quarter. Masimo comprises about 3.2% of New Amsterdam Partners LLC NY’s portfolio, making the stock its 2nd biggest holding. New Amsterdam Partners LLC NY’s holdings in Masimo were worth $12,425,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. United Services Automobile Association lifted its position in shares of Masimo by 0.7% during the 2nd quarter. United Services Automobile Association now owns 71,510 shares of the medical equipment provider’s stock worth $6,983,000 after buying an additional 485 shares during the last quarter. US Bancorp DE lifted its position in shares of Masimo by 36.9% during the 2nd quarter. US Bancorp DE now owns 1,980 shares of the medical equipment provider’s stock worth $193,000 after buying an additional 534 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its position in shares of Masimo by 3.0% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 18,628 shares of the medical equipment provider’s stock worth $1,819,000 after buying an additional 535 shares during the last quarter. Security Asset Management lifted its position in shares of Masimo by 4.4% during the 3rd quarter. Security Asset Management now owns 12,834 shares of the medical equipment provider’s stock worth $1,598,000 after buying an additional 539 shares during the last quarter. Finally, Janney Capital Management LLC lifted its position in shares of Masimo by 11.2% during the 2nd quarter. Janney Capital Management LLC now owns 6,115 shares of the medical equipment provider’s stock worth $597,000 after buying an additional 614 shares during the last quarter. Hedge funds and other institutional investors own 83.22% of the company’s stock.

In related news, EVP Bilal Muhsin sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 6th. The stock was sold at an average price of $117.75, for a total transaction of $2,355,000.00. Following the completion of the sale, the executive vice president now owns 10,000 shares of the company’s stock, valued at $1,177,500. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ramshorst David J. Van sold 1,325 shares of the firm’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $125.00, for a total value of $165,625.00. Following the sale, the insider now directly owns 2,325 shares of the company’s stock, valued at approximately $290,625. The disclosure for this sale can be found here. In the last three months, insiders sold 676,033 shares of company stock valued at $81,000,568. Insiders own 12.60% of the company’s stock.

Several equities analysts have commented on the company. Stifel Nicolaus increased their target price on Masimo from $108.00 to $112.00 and gave the company a “buy” rating in a research report on Thursday, August 2nd. Needham & Company LLC assumed coverage on Masimo in a research report on Friday, September 14th. They issued a “buy” rating for the company. BidaskClub upgraded Masimo from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 17th. Zacks Investment Research downgraded Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, August 1st. Finally, Piper Jaffray Companies increased their target price on Masimo to $120.00 and gave the company a “neutral” rating in a research report on Thursday, November 1st. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Masimo currently has a consensus rating of “Buy” and an average price target of $114.40.

Masimo stock opened at $114.84 on Wednesday. The stock has a market capitalization of $5.90 billion, a price-to-earnings ratio of 46.87, a PEG ratio of 2.62 and a beta of 1.11. Masimo Co. has a 12 month low of $80.69 and a 12 month high of $126.89.

Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Wednesday, October 31st. The medical equipment provider reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.02. The company had revenue of $210.58 million during the quarter, compared to analysts’ expectations of $207.62 million. Masimo had a return on equity of 20.29% and a net margin of 17.08%. The business’s quarterly revenue was up 8.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.56 earnings per share. On average, equities research analysts anticipate that Masimo Co. will post 2.92 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This article was first reported by Week Herald and is owned by of Week Herald. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://weekherald.com/2018/11/07/masimo-co-masi-stake-increased-by-new-amsterdam-partners-llc-ny.html.

Masimo Profile

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

See Also: What is the NASDAQ?

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply